Virtual Medicinal Product (VMP)
-
Pembrolizumab 50mg powder for solution for infusion vials
Name Details
Current Name
Pembrolizumab 50mg powder for solution for infusion vials
|
Start Date
28-07-2015
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Powder for solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L01FF02
BNF |
Current BNF
08010500
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
08010500
|
Start Date
04-07-2016
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
30033011000001108 |
28-07-2015 |
|
VMP Ingredients
VMP ingredients table
Pembrolizumab |
Based on Ingredient Substance |
|
50 mg |
|
Name
Pembrolizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Pembrolizumab
-
VMP
(Current) Pembrolizumab 50mg powder for soluti...
Virtual Medicinal Product Pack (VMPP) Information